Pfizer

Pfizer and BioNTech companies have offered to supply 50 million doses of their COVID-19 vaccine to Africa for healthcare workers. The vaccine will be delivered in batches from March to the end of 2021.

Meanwhile, Pfizer had broken through the downtrend resistance line and then tested it. The price moves in an ascending channel and the most pleasant entry point is 36.6 if you know what I mean.

BioNTech
스냅샷

Best regards EXCAVO
2021biontechChart PatternsCoronavirus (COVID-19)Technical IndicatorsPFIZERStocksTrend Analysis

GET VIP group + EXCAVO portfolio for FREE
Register
partner.bybit.com/b/excavo

AFTER TXT TO

t.me/excavo - admin

t.me/excavonews
t.me/excavochannel
또한 다음에서도:

관련 발행물

면책사항